# Hiberna Corp: Form D filing

Hiberna Corp, a biotechnology company in Boulder, CO, filed a Form D with the SEC in 2009. The latest, on March 13, 2009, reports $100,000 sold of a $1 million offering to 1 investor.

Find out what Hiberna Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Hiberna%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Hiberna%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fhiberna-corp-1403111)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Hiberna%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Hiberna%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fhiberna-corp-1403111)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Colorado](https://specstream.ai/data/form-d/state/colorado): 1,787 rows, by operating companies, filed since November 1, 2024, $89.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/colorado
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1900 Ninth Str, Suite 200, Boulder, CO, 80302
- Phone: (303) 408-0579
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: De
- Year incorporated: 2006
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1403111

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 13, 2009 | New notice | $1,000,000 | $100,000 | $900,000 | 1 | Mar 12, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1403111/000140311109000002/0001403111-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Thomas Marr | Executive Officer, Director, Promoter |  |
| Leslie Leinwand | Director |  |
| Kyle Lefkoff | Director |  |
| Rex O'Neal | Executive Officer |  |

## Other biotechnology companies in Colorado that filed recently

- [HealthVest Fund V LLC](https://specstream.ai/data/form-d/company/healthvest-fund-v-llc-2163605) offering · Nov 5, 2026
- [GelSana Therapeutics, Inc.](https://specstream.ai/data/form-d/company/gelsana-therapeutics-inc-2002665) $4.4 million · Oct 8, 2026
- [Renovare Therapeutics, Inc.](https://specstream.ai/data/form-d/company/renovare-therapeutics-inc-2158361) $100,000 · Oct 2, 2026
- [EnteroTrack, LLC](https://specstream.ai/data/form-d/company/enterotrack-llc-1612812) $2 million · Sep 25, 2026

[Every Form D from the week of Mar 9, 2009](https://specstream.ai/data/form-d/week/2009-03-09) · [All recent filings in Colorado](https://specstream.ai/data/form-d/state/colorado) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Hiberna Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).